Biopolymer Methods in Tissue Engineering pp 49-64 | Cite as
Characterization of a Calcium Phosphate-Based Matrix for rhBMP-2
- 1 Citations
- 949 Downloads
Abstract
Bone morphogenetic proteins (BMPs) are members of the transforming growth factor-β (TGF-β) superfamily of proteins that have crucial roles in growth and regeneration of skeletal tissues. In particular, recombinant human bone morphogenetic protein-2 (rhBMP-2) has been shown to induce new bone formation by differentiation of mesenchymal progenitor cells into osteoblasts (1). BMPs act locally, and thus for a clinically beneficial outcome, a carrier matrix is required to retain therapeutic levels of BMP at the repair site (2,3). The potent osteoinductive ability of BMP-2 has been demonstrated in numerous preclinical (4, 5, 6, 7, 8, 9) and clinical studies (10, 11, 12, 13, 14). Recent data from clinical trials have reported success in the areas of open fracture repair (10,14), interbody spinal fusion (11), and maxillofacial reconstruction (12,13) using rhBMP-2 delivered in an absorbable collagen sponge (ACS). Because rhBMP-2/ACS requires implantation, there is a continuing need for an easily injectable carrier to deliver rhBMP-2 percutaneously to closed fractures. Here, we outline characterization of a calcium phosphate (CaP)-based injectable carrier as a delivery matrix for rhBMP-2.
Keywords
Mean Residence Time Dose Calibrator Gamma Scintigraphy Absorbable Collagen Sponge Retention ProfileReferences
- 1.Wozney, J. M. (1990) The bone morphogenetic protein family and osteogenesis. Mol. Reprod. Dev. 32, 160–167.CrossRefGoogle Scholar
- 2.Winn, S. R., Uludag, H., and Hollinger, J. O. (1998) Sustained release emphasizing recombinant human bone morphogenetic protein-2. Adv. Drug Delivery Rev. 31, 303–318.CrossRefGoogle Scholar
- 3.Li, R. H. and Wozney, J. M. (2001) Delivering on the promise of bone morphogenetic proteins. Trends Biotechnol. 19(7), 255–265.CrossRefGoogle Scholar
- 4.Gerhart, T. N., Kirker-Head, C. A., Kriz, M. J., et al. (1993) Healing segmental femoral defects in sheep using recombinant human bone morphogenetic protein-2. Clin. Orthop. 293, 317–326.Google Scholar
- 5.Hanisch, O., Tatakis, D. H., Rohrer, M.D., et al. (1997) Bone formation and osseointegration stimulated by rhBMP-2 following subantral augmentation procedures in nonhuman primates. Int. J. Oral Maxillofac. Implants 12, 785–792.Google Scholar
- 6.Muschler, G. F., Hyodo, A., Manning, T., et al. (1994) Evaluation of human bone morphogenetic protein-2 in a canine fusion model. Clin. Orthop. 308, 229–240.Google Scholar
- 7.Sigurdsson, T. J., Lee, M. B., Kubota, K., et al. (1995) Periodontal repair in dogs: recombinant human bone morphogenetic protein-2 significantly enhances periodontal regeneration. J. Periodont. 66, 131–138.Google Scholar
- 8.Zegzula, H. D., Buck, D. C., Brekke, J., et al. (1997) Bone formation with use of rhBMP-2 (recombinant human bone morphogenetic protein-2). J. Bone Jt. Surg. Am. 79, 1778–1790.Google Scholar
- 9.Bax, B. E., Wozney, J. M., and Ashhurst, D. E. (1999) Bone morphogenetic protein-2 increases the rate of callus formation after fracture of the rabbit tibia. Calcif. Tiss. Int. 65, 83–89.CrossRefGoogle Scholar
- 10.Riedel, G. E. and Valentin-Opran, A. (1999) Clinical evaluation of rhBMP-2/ACS in orthopedic trauma: a progress report. Orthopedics 22(7), 663–665.Google Scholar
- 11.Boden, S. D., Zdeblick, T. A., Sandhu, H. S., and Heim, S. E. (1999) The use of rhBMP-2 in interbody fusion cages: definitive evidence of osteoinduction in humans, in Transactions of the Annual Meeting of the American Academy of Orthopaedic Surgeons, Anaheim, CA, p. 41.Google Scholar
- 12.Boyne, P. J., Marx, R. E., Nevins, M., et al. (1997) A feasibility study evaluating rhBMP-2/absorbable collagen sponge for maxillary sinus floor augmentation. International Periodo, J. Resto. Dent. 17(1), 11–25.Google Scholar
- 13.Howell, T. H., Fiorellini, J., Jones, A., et al. (1997) A feasibility study evaluating rhBMP-2/absorbable collagen sponge device for local alveolar ridge preservation or augmentation. Int. J. Periodontics Restorative Dent. 17, 124–139.Google Scholar
- 14.BESTT (The BMP-2 Evaluation in Surgery for Tibial Trauma Study Group), Govender, S., Csimma, C., et al. (2002) Recombinant human bone morphogenetic protein-2 for open tibial fractures: a prospective, controlled, randomized study in 450 patients. J. Bone and Jt. Surg. 84-A(12), 2123–2134.Google Scholar
- 15.Frankenburg, E., Goldstein, S., Bauer, T., Harris, S., and Poser, R. (1998) Biomechanical and histological evaluation of a calcium phosphate cement. J. Bone Jt. Surg. 80-A(8), 1112–1124.Google Scholar
- 16.Lobenhoffer, P., Gerich, T., Witte, F., and Tscherne, H. (2002) Use of an injectable calcium phosphate bone cement in the treatment of tibial plateau bone fractures: a prospective study of twenty-six cases with twenty-month mean followup. J. Orthop. Trauma 16(3), 143–149.CrossRefGoogle Scholar
- 17.Reddi, S., Stevens, M., Kline, S., and Villaneuva, P. (1999) Hydroxyapatite cement in craniofacial trauma surgery: indications and early experience. Craniomaxillofac, J. Trauma 5(1), 7–12.Google Scholar
- 18.Heini, P. and Berlemann, U. (2001) Bone substitutes in vertebroplasty. Eur. Spine J. 10(Suppl 2), S205–S213.Google Scholar
- 19.Spivak J. and Hasharoni, A. (2001) Use of hydroxyapatite in spine surgery. Eur. Spine J. 10(Suppl 2), S197–S204.CrossRefGoogle Scholar
- 20.Schmitz, J. P., Hollinger, J. O. and Milam, S. B. (1999) Reconstruction of bone using calcium phosphate bone cements. J. Oral Maxillofac. Surg. 57, 1122–1126.CrossRefGoogle Scholar
- 21.Lee, D., Tofighi, A., Aiolova, M., et al. (1999) a-BSM: a biomimetic bone substitute and drug delivery vehicle. Clin. Orthop. 367S, S396–S405.Google Scholar
- 22.Knaack, D., Goad, E., Aiolova, M., et al. (1997) Novel fully resorbable calcium phosphate bone substitute. J. Bone Miner. Res. 12(1), S202.Google Scholar
- 23.Edwards, I., R., Zabka, A., Hayashi, K., et al. (2000) Accelerated fracture healing by percutaneous injection of rhBMP-2 and alpha-BSM, in Transactions of the Annual Meeting of the Orthopaedic Research Society, Orlando, FL., p. 850.Google Scholar
- 24.Seeherman, H., Aiolova, M., Bouxsein, M., and Wozney, J. (2001) A single injection of rhBMP-2/calcium phosphate paste accelerates healing in a nonhuman primate osteotomy model, in Transactions of the Annual Meeting of the Orthopaedic Research Society, San Francisco, CA, p. 251.Google Scholar
- 25.Hollinger, J., Buck, D., Schmitt, J., et al. (1999) An injectable endothermically-setting calcium phosphate material bridges critical-sized defects in rabbits in combination with rhBMP-2, in Transactions of the Annual Meeting of the Orthopaedic Research Society, Anaheim, CA, p. 509.Google Scholar
- 26.Israel, D. I., Nove, J., Kerns, K. M., et al. (1992) Expression and characterization of bone morphogenetic protein-2 in chinese hamster ovary cells. Growth Factors 7, 139–150.CrossRefGoogle Scholar
- 27.Thies, R. S., Bauduy, M., Ashton, B. A., et al. (1992) Recombinant human bone morphogenetic protein-2 induces osteoblastic differentiation in W-20-17 stromal cells. Endocrinology 130(3), 1318–1324.CrossRefGoogle Scholar
- 28.Schenk, R. K., Olah, A.J., and Herrmann, W. (1984) Preparation of calcified tissues for light microscopy, in Methods of Calcified Tissue Preparation (Dickson, G. R., ed.), Elsevier Science, New York, NY, pp. 1–42.Google Scholar
- 29.Wozney, J. M., Rosen, V., Celeste, A. J., et al. (1988) Novel regulators of bone formation: molecular clones and activities. Science 242, 1528–1534.CrossRefGoogle Scholar